No Data
No Data
DISA Subsidiary Starts Trial Deployment of Vision Screening Tech in Vietnam
DISA's (SGX:532) subsidiary, Digital Life Line, started a trial deployment of its Automated Visual Acuity Test Device (AVAT) in collaboration with Eye Hospital Social Enterprise Company in Vietnam, ac
DISA's Subsidiary Signs MoU for Trial Deployment of Ophthalmology Solution
DISA's (SGX:532) subsidiary, DLL, signed a memorandum of understanding with Vietnam-based Alina Eye Hospital for the trial deployment of its AI-powered ophthalmology solution, AVAT, according to a fil
Disa Unit Completes Trial Rollout of Eye Screening Device at Singapore Public Hospital; Shares Balloon 100%
Digital Life Line, a subsidiary of Disa's (SGX:532) wholly-owned DiSa Digital Safety, completed the first trial rollout of a medical device for eye screening in a major public hospital in Singapore, a
DISA Shrinks Loss in Fiscal First Half
DISA (SGX:532) saw a 38.2% decline in attributable loss for the six months ended Dec. 31, 2023, to SG$686,000 from SG$1.1 million during the year-ago period. Loss per share remained consistent at SG$0
DiSa Unit Awarded European Quality Certification Mark for COVID-19 ART Kit
04:31 AM EDT, 05/24/2022 (MT Newswires) -- DiSa (SGX:532) said its its step down subsidiary Digital Life Line has been awarded CE-IVD (In-Vitro Diagnostic) mark for its Pasport Gold Sars-CoV-2 ART kit
DISA Grants 10 Million Share Options Under Employee Share Option Scheme; Shares Surge 14%
12:59 AM EST, 01/13/2022 (MT Newswires) -- DISA (SGX:532) granted 10 million share options on Thursday under its employee share option scheme 2021, according to a same-day bourse disclosure. The opti
No Data